Last updated February, 3 2014 581.217 documents processed, 14.657.417 references and 5.549.674 citations

PharmacoEconomics / Springer Healthcare | Adis

[Raw data] [Main indicators] [Most cited papers] [cites used to compute the impact factor] [Recent citations ][documents published in EconPapers] [Keep updated about new citations] [Missing citations? Add them now] [Incorrect content? Let us know]

Main indicators

Raw data:

IF AIF DOC CDO CCU CIF CIT D2Y C2Y %SC CiY II AII
19900.08000000.04
19910.08000000.04
19920.08000000.04
19930.09000000.05
19940.1000000.04
19950.19000000.07
19960.23000000.09
19970.29000000.1
19980.29000000.11
19990.33000000.14
20000.421100000.16
20010.44100100.17
20020.44100100.19
20030.46100000.2
20040.531200000.22
20050.562400100.23
20060.531500300.22
20070.462700300.19
20080.492900300.21
20090.55968018400.2
20100.050.469616430.024661300.16
20110.090.57164140.0901551400.22
20120.30.6694258520.289629040.040.26
 
 
IF: Impact Factor: C2Y / D2Y
AIF: Average Impact Factor for series in RePEc in year y
DOC: Number of documents published in year y
CDO: Cumulative number of documents published until year y
CCU: Cumulative number of citations to papers published until year y
CIF: Cumulative impact factor
CIT: Number of citations to papers published in year y
D2Y: Number of articles published in y-1 plus y-2
C2Y: Cites in y to articles published in y-1 plus y-2
%SC: Percentage of selft citations in y to articles published in y-1 plus y-2
CiY: Cites in year y to documents published in year y
II: Immediacy Index: CiY / Documents.
AII: Average Immediacy Index for series in RePEc in year y

 

Most cited documents in this series:

YearTitleCited
14
6
6
5
2010Cetuximab for Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck: A NICE Single Technology Appraisal. (2010). Bagust, Adrian ; Dundar, Yenal ; Dickson, Rumona ; Shaw, Richard ; Fleeman, Nigel ; Greenhalgh, Janette ; McLeod, Claire ; Proudlove, Christine ; Boland, Angela . In: PharmacoEconomics. RePEc:wkh:phecon:v:28:y:2010:i:6:p:439-448.

Full description at Econpapers || Download paper

4
4
4
4
4
2010Impact of European Pharmaceutical Price Regulation on Generic Price Competition: A Review. (2010). Puig-Junoy, Jaume . In: PharmacoEconomics. RePEc:wkh:phecon:v:28:y:2010:i:8:p:649-663.

Full description at Econpapers || Download paper

4
2010Are Cancer Drugs Less Likely to be Recommended for Listing by the Pharmaceutical Benefits Advisory Committee in Australia?. (2010). Salkeld, Glenn ; Kelly, Patrick J. ; Stockler, Martin R. ; Chim, Lesley . In: PharmacoEconomics. RePEc:wkh:phecon:v:28:y:2010:i:6:p:463-475.

Full description at Econpapers || Download paper

4
2012Dabigatran Etexilate for the Prevention of Venous Thromboembolism in Patients Undergoing Elective Hip or Knee Surgery: A NICE Single Technology Appraisal. (2012). Carroll, Christopher ; Holmes, Michael ; Papaioannou, Diana . In: PharmacoEconomics. RePEc:wkh:phecon:v:30:y:2012:i:2:p:137-146.

Full description at Econpapers || Download paper

3
2010Alitretinoin for Severe Chronic Hand Eczema: A NICE Single Technology Appraisal. (2010). Ingram, John R. ; Griffin, Susan ; Duffy, Steven ; Slack, Russell ; Woolacott, Nerys ; Paulden, Mike ; Sculpher, Mark ; Rodgers, Mark . In: PharmacoEconomics. RePEc:wkh:phecon:v:28:y:2010:i:5:p:351-362.

Full description at Econpapers || Download paper

3
3
3
2012Dronedarone for the Treatment of Atrial Fibrillation: A NICE Single Technology Appraisal. (2012). Pepper, Chris ; Palmer, Stephen ; Woolacott, Nerys ; Sarowar, Muhammad ; Stevenson, Matt ; Maund, Emma ; Fox, David ; McKenna, Claire . In: PharmacoEconomics. RePEc:wkh:phecon:v:30:y:2012:i:1:p:35-46.

Full description at Econpapers || Download paper

3
2010Single Technology Appraisal at the UK National Institute for Health and Clinical Excellence: A Source of Evidence and Analysis for Decision Making Internationally. (2010). Sculpher, Mark . In: PharmacoEconomics. RePEc:wkh:phecon:v:28:y:2010:i:5:p:347-349.

Full description at Econpapers || Download paper

3
2009Weighting Must Wait: Incorporating Equity Concerns into Cost-Effectiveness Analysis May Take Longer than Expected. (2009). Tsuchiya, Aki ; McCabe, Christopher ; Wailoo, Allan . In: PharmacoEconomics. RePEc:wkh:phecon:v:27:y:2009:i:12:p:983-989.

Full description at Econpapers || Download paper

3
2010The Economics of Comparative Effectiveness Studies: Societal and Private Perspectives and their Implications for Prioritizing Public Investments in Comparative Effectiveness Research. (2010). Basu, Anirban ; Conti, Rena ; Meltzer, David . In: PharmacoEconomics. RePEc:wkh:phecon:v:28:y:2010:i:10:p:843-853.

Full description at Econpapers || Download paper

3
3
3
2010Using Conjoint Analysis and Choice Experiments to Estimate QALY Values: Issues to Consider. (2010). Flynn, Terry N.. In: PharmacoEconomics. RePEc:wkh:phecon:v:28:y:2010:i:9:p:711-722.

Full description at Econpapers || Download paper

2
2
2012Losing Sight of the Wood for the Trees: Some Issues in Describing and Valuing Health, and Another Possible Approach. (2012). Lee, Henry ; Peasgood, Tessa ; Dolan, Paul . In: PharmacoEconomics. RePEc:wkh:phecon:v:30:y:2012:i:11:p:1035-1049.

Full description at Econpapers || Download paper

2
2
2
2009A Cost-Effectiveness Model Comparing Rivaroxaban and Dabigatran Etexilate with Enoxaparin Sodium as Thromboprophylaxis after Total Hip and Total Knee Replacement in the Irish Healthcare Setting. (2009). Walsh, Cathal ; Barry, Michael ; Tilson, Lesley ; McCullagh, Laura . In: PharmacoEconomics. RePEc:wkh:phecon:v:27:y:2009:i:10:p:829-846.

Full description at Econpapers || Download paper

2
2010The State of Health Economic Evaluation Research in Nigeria: A Systematic Review. (2010). Oladapo, Abiola O. ; Khoza, Star ; Gavaza, Paul ; Rascati, Karen L.. In: PharmacoEconomics. RePEc:wkh:phecon:v:28:y:2010:i:7:p:539-553.

Full description at Econpapers || Download paper

2
2
2009Cost Effectiveness of Influenza Vaccination in Older Adults: A Critical Review of Economic Evaluations for the 50- to 64-Year Age Group. (2009). Newall, Anthony T. ; Harsley, Stuart ; Scuffham, Paul A. ; Kelly, Heath . In: PharmacoEconomics. RePEc:wkh:phecon:v:27:y:2009:i:6:p:439-450.

Full description at Econpapers || Download paper

2
2010The Value of Value of Information: Best Informing Research Design and Prioritization Using Current Methods. (2010). Willan, Andrew R. ; Eckermann, Simon ; Karnon, Jon . In: PharmacoEconomics. RePEc:wkh:phecon:v:28:y:2010:i:9:p:699-709.

Full description at Econpapers || Download paper

2
2010Varenicline: A Pharmacoeconomic Review of its Use as an Aid to Smoking Cessation. (2010). Keating, Gillian M. ; Lyseng-Williamson, Katherine A.. In: PharmacoEconomics. RePEc:wkh:phecon:v:28:y:2010:i:3:p:231-254.

Full description at Econpapers || Download paper

2
2009The Cost of Disability and Medically Related Absenteeism Among Employees with Multiple Sclerosis in the US. (2009). Phillips, Amy L. ; Samuels, Seth ; Davis, Matthew ; Ivanova, Jasmina I. ; Birnbaum, Howard G. ; Meletiche, Dennis . In: PharmacoEconomics. RePEc:wkh:phecon:v:27:y:2009:i:8:p:681-691.

Full description at Econpapers || Download paper

2
2010Cant Get No Satisfaction? Will Pay for Performance Help?: Toward an Economic Framework for Understanding Performance-Based Risk-Sharing Agreements for Innovative Medical Products. (2010). Towse, Adrian ; Garrison, Louis P.. In: PharmacoEconomics. RePEc:wkh:phecon:v:28:y:2010:i:2:p:93-102.

Full description at Econpapers || Download paper

2
2
2009Calibration Methods Used in Cancer Simulation Models and Suggested Reporting Guidelines. (2009). Knudsen, Amy B. ; McMahon, Pamela M. ; Stout, Natasha K. ; G. Scott. Gazelle, ; Chung Yin. Kong, . In: PharmacoEconomics. RePEc:wkh:phecon:v:27:y:2009:i:7:p:533-545.

Full description at Econpapers || Download paper

2
2010Access with Evidence Development Schemes: A Framework for Description and Evaluation. (2010). McCabe, Christopher ; Stafinski, Tania ; Edlin, Richard ; Menon, Devidas . In: PharmacoEconomics. RePEc:wkh:phecon:v:28:y:2010:i:2:p:143-152.

Full description at Econpapers || Download paper

2
2
2
200930 Years of Pharmaceutical Cost-Utility Analyses: Growth, Diversity and Methodological Improvement. (2009). Fang, Chi-Hui ; Neumann, Peter J. ; Cohen, Joshua T.. In: PharmacoEconomics. RePEc:wkh:phecon:v:27:y:2009:i:10:p:861-872.

Full description at Econpapers || Download paper

2
2
2012Golimumab for the Treatment of Psoriatic Arthritis: A NICE Single Technology Appraisal. (2012). EPSTEIN, DAVID ; Bojke, Laura ; Woolacott, Nerys ; Sculpher, Mark ; Light, Kate ; Bruce, Ian N. ; Yang, Huiqin ; Craig, Dawn . In: PharmacoEconomics. RePEc:wkh:phecon:v:30:y:2012:i:4:p:257-270.

Full description at Econpapers || Download paper

2
1
1
1
2009Holistic Preferences for 1-Year Health Profiles Describing Fluctuations in Health: The Case of Chronic Obstructive Pulmonary Disease. (2009). Lamers, Leida M. ; Maureen P. M. H. Rutten-van Mlken, ; Hoogendoorn, Martine . In: PharmacoEconomics. RePEc:wkh:phecon:v:27:y:2009:i:6:p:465-477.

Full description at Econpapers || Download paper

1
2010An Analysis of NICEs Restricted (or Optimized) Decisions. (2010). Devlin, Nancy ; ONeill, Phill . In: PharmacoEconomics. RePEc:wkh:phecon:v:28:y:2010:i:11:p:987-993.

Full description at Econpapers || Download paper

1
2010Pharmacoeconomic Evaluation in Ireland: A Review of the Process. (2010). OLeary, Aisling ; Barry, Michael ; Tilson, Lesley ; Usher, Cara . In: PharmacoEconomics. RePEc:wkh:phecon:v:28:y:2010:i:4:p:307-322.

Full description at Econpapers || Download paper

1
2009Methods for Measuring Temporary Health States for Cost-Utility Analyses. (2009). Wright, Davene R. ; Miksad, Rebecca A. ; Prosser, Lisa A. ; J. Shannon. Swan, ; Wittenberg, Eve . In: PharmacoEconomics. RePEc:wkh:phecon:v:27:y:2009:i:9:p:713-723.

Full description at Econpapers || Download paper

1
1

Citing documents used to compute impact factor 29:

YearTitleSee
2012Incorporating Calibrated Model Parameters into Sensitivity Analyses. (2012). Kruzikas, Denise ; Pawar, Vivek ; Sanon, Myrlene ; Weinstein, Milton ; Gilmore, Kristen ; Taylor, Douglas . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:2:p:119-126.

Full description at Econpapers || Download paper

[Citation Analysis]
2012Comparative Effectiveness and Child Health. (2012). Prosser, Lisa . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:8:p:637-645.

Full description at Econpapers || Download paper

[Citation Analysis]
2012Cost Effectiveness of Therapeutic Interventions in Ankylosing Spondylitis. (2012). Fautrel, Bruno ; Gaujoux-Viala, Cecile . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:12:p:1145-1156.

Full description at Econpapers || Download paper

[Citation Analysis]
2012Cost-effectiveness of lapatinib plus capecitabine in women with HER2+ metastatic breast cancer who have received prior therapy with trastuzumab. (2012). Cameron, David ; Delea, Thomas ; Tappenden, Paul ; Sofrygin, Oleg ; Walker, Mel ; Amonkar, Mayur ; Karnon, Jon ; Browning, Dominy . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:13:y:2012:i:5:p:589-603.

Full description at Econpapers || Download paper

[Citation Analysis]
2012Eltrombopag for the Treatment of Chronic Immune or Idiopathic Thrombocytopenic Purpura. (2012). Jenkinson, David ; Jia, Xueli ; Mowatt, Graham ; Boyers, Dwayne . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:6:p:483-495.

Full description at Econpapers || Download paper

[Citation Analysis]
2012Golimumab for the Treatment of Psoriatic Arthritis. (2012). Epstein, David ; Woolacott, Nerys ; Sculpher, Mark ; Bojke, Laura ; Light, Kate ; Bruce, Ian ; Yang, Huiqin ; Craig, Dawn . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:4:p:257-270.

Full description at Econpapers || Download paper

[Citation Analysis]
2012Dronedarone for the Treatment of Atrial Fibrillation. (2012). Pepper, Chris ; Palmer, Stephen ; Woolacott, Nerys ; Sarowar, Muhammad ; Stevenson, Matt ; Maund, Emma ; Fox, David ; McKenna, Claire . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:1:p:35-46.

Full description at Econpapers || Download paper

[Citation Analysis]
2012New Clinical Insights into Chronic Obstructive Pulmonary Disease and Their Implications for Pharmacoeconomic Analyses. (2012). Mapel, Douglas ; Roberts, Melissa . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:10:p:869-885.

Full description at Econpapers || Download paper

[Citation Analysis]
2012Omalizumab for the Treatment of Severe Persistent Allergic Asthma in Children Aged 6–11 Years. (2012). McKenna, Claire ; Griffin, Susan ; Walker, Simon ; Woolacott, Nerys ; Wright, Kath ; Burch, Jane ; Paton, James . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:11:p:991-1004.

Full description at Econpapers || Download paper

[Citation Analysis]
2012Reimbursement Decisions of the All Wales Medicines Strategy Group. (2012). Hughes, Dyfrig ; Linley, Warren . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:9:p:779-794.

Full description at Econpapers || Download paper

[Citation Analysis]
2012A systematic review of coverage decision-making on health technologies—Evidence from the real world. (2012). Fischer, Katharina. In: Health Policy. RePEc:eee:hepoli:v:107:y:2012:i:2:p:218-230.

Full description at Econpapers || Download paper

[Citation Analysis]
2012Common Drug Review Recommendations. (2012). Rocchi, Angela ; Goeree, Ron ; Hopkins, Robert ; Miller, Elizabeth . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:3:p:229-246.

Full description at Econpapers || Download paper

[Citation Analysis]
2012Osteoporotic Fractures. (2012). Badamgarav, Enkhe ; Mikyas, Yeshi ; Budhia, Sangeeta ; Tang, Michael . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:2:p:147-170.

Full description at Econpapers || Download paper

[Citation Analysis]
2012Developing Adolescent-Specific Health State Values for Economic Evaluation. (2012). Terlich, Frances ; Flynn, Terry ; Sawyer, Michael ; Stevens, Katherine ; Ratcliffe, Julie ; Brazier, John . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:8:p:713-727.

Full description at Econpapers || Download paper

[Citation Analysis]
2012Health Utility Elicitation. (2012). Wittenberg, Eve ; Grosse, Scott ; Prosser, Lisa . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:2:p:83-86.

Full description at Econpapers || Download paper

[Citation Analysis]
2012Private Manufacturers’ Thresholds to Invest in Comparative Effectiveness Trials. (2012). Basu, Anirban ; Meltzer, David . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:10:p:859-868.

Full description at Econpapers || Download paper

[Citation Analysis]
2012Quetiapine. (2012). Plosker, Greg . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:7:p:611-631.

Full description at Econpapers || Download paper

[Citation Analysis]
2012Value-of-Information Analysis to Reduce Decision Uncertainty Associated with the Choice of Thromboprophylaxis after Total Hip Replacement in the Irish Healthcare Setting. (2012). Walsh, Cathal ; Barry, Michael ; McCullagh, Laura . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:10:p:941-959.

Full description at Econpapers || Download paper

[Citation Analysis]
2012Value of Information and Pricing New Healthcare Interventions. (2012). Willan, Andrew ; Eckermann, Simon . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:6:p:447-459.

Full description at Econpapers || Download paper

[Citation Analysis]
2012Pharmaceutical prices under regulation: Tiered co-payments and reference pricing in Germany. (2012). Suppliet, Moritz ; Herr, Annika. In: DICE Discussion Papers. RePEc:zbw:dicedp:48.

Full description at Econpapers || Download paper

[Citation Analysis]
2012.

Full description at Econpapers || Download paper

[Citation Analysis]
2012Economic Evaluation of Smoking-Cessation Therapies. (2012). Bolin, Kristian . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:7:p:551-564.

Full description at Econpapers || Download paper

[Citation Analysis]
2012Bevacizumab for Metastatic Colorectal Cancer. (2012). Pandor, Abdullah ; Whyte, Sophie ; Stevenson, Matt . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:12:p:1119-1132.

Full description at Econpapers || Download paper

[Citation Analysis]
2012Dabigatran Etexilate for the Prevention of Venous Thromboembolism in Patients Undergoing Elective Hip or Knee Surgery. (2012). Carroll, Christopher ; Holmes, Michael ; Papaioannou, Diana . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:2:p:137-146.

Full description at Econpapers || Download paper

[Citation Analysis]
2012Cost Effectiveness of Rituximab for Non-Hodgkin’s Lymphoma. (2012). Gerber, Andreas ; Stock, Stephanie ; Auweiler, Philipp ; Muller, Dirk . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:7:p:537-549.

Full description at Econpapers || Download paper

[Citation Analysis]
2012The State of Health Economic Research in South Africa. (2012). Oladapo, Abiola ; Khoza, Star ; Gavaza, Paul ; Rascati, Karen . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:10:p:925-940.

Full description at Econpapers || Download paper

[Citation Analysis]
2012Assessing the Quality of Pharmacoeconomic Studies in India. (2012). Desai, Pooja ; Rascati, Karen ; Chandwani, Hitesh . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:9:p:749-762.

Full description at Econpapers || Download paper

[Citation Analysis]
2012Pharmaceuticals Delivery in Ireland. Getting a Bigger Bang for the Buck. (2012). Nolan, Anne ; Lyons, Sean ; Gorecki, Paul K. ; Brick, Aoife . In: Research Series. RePEc:esr:resser:rs24.

Full description at Econpapers || Download paper

[Citation Analysis]
2012Cost Effectiveness of Guanfacine Extended-Release versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder. (2012). Wu, Eric ; Sikirica, Vanja ; Hodgkins, Paul ; Lu, Mei ; Erder, M. ; Chen, Kristina ; Xie, Jipan ; Signorovitch, James . In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:10:y:2012:i:6:p:381-395.

Full description at Econpapers || Download paper

[Citation Analysis]

Cites in year: CiY

Recent citations received in: 2012

YearTitleSee
2012The Authors’ Reply. (2012). Delwel, Gepke ; Hoomans, Ties ; Roer, Nicole ; Severens, Johan . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:10:p:980-980.

Full description at Econpapers || Download paper

[Citation Analysis]
2012Omalizumab for the Treatment of Severe Persistent Allergic Asthma in Children Aged 6–11 Years. (2012). McKenna, Claire ; Griffin, Susan ; Walker, Simon ; Woolacott, Nerys ; Wright, Kath ; Burch, Jane ; Paton, James . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:11:p:991-1004.

Full description at Econpapers || Download paper

[Citation Analysis]
2012Bevacizumab for Metastatic Colorectal Cancer. (2012). Pandor, Abdullah ; Whyte, Sophie ; Stevenson, Matt . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:12:p:1119-1132.

Full description at Econpapers || Download paper

[Citation Analysis]
2012Eltrombopag for the Treatment of Chronic Immune or Idiopathic Thrombocytopenic Purpura. (2012). Jenkinson, David ; Jia, Xueli ; Mowatt, Graham ; Boyers, Dwayne . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:6:p:483-495.

Full description at Econpapers || Download paper

[Citation Analysis]

Recent citations received in: 2010

YearTitleSee

Recent citations received in: 2009

YearTitleSee

Warning!! This is still an experimental service. The results of this service should be interpreted with care, especially in research assessment exercises. The processing of documents is automatic. There still are errors and omissions in the identification of references. We are working to improve the software to increase the accuracy of the results.

Source data used to compute the impact factor of RePEc series.